PA · Healthcare

Oncodesign Precision Medicine (ALOPM)

Biotechnology

Oncodesign Precision Medicine (ALOPM) is listed on PA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ALOPM

P/E ratio

25.00

Oncodesign Precision Medicine (ALOPM) — FAQ

What is ALOPM's P/E ratio?

The price-to-earnings (P/E) ratio for Oncodesign Precision Medicine (ALOPM) is 25.00 (data as of 2026-05-24).

Does Oncodesign Precision Medicine pay a dividend?

Dividend yield is not available in the current snapshot for Oncodesign Precision Medicine (ALOPM). Check the MyAverix Finance app for the latest dividend data.

What sector is Oncodesign Precision Medicine in?

Oncodesign Precision Medicine (ALOPM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ALOPM listed on?

ALOPM is listed on PA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)